CA-A Cancer Journal for Clinicians

Papers
(The H4-Index of CA-A Cancer Journal for Clinicians is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries51023
Cancer Statistics, 202111276
Cancer statistics, 20229749
Cancer statistics, 20234567
Management of glioblastoma: State of the art and future directions918
Cancer treatment and survivorship statistics, 2022887
Current treatment and recent progress in gastric cancer747
Breast Cancer Statistics, 2022613
Cancer statistics for adolescents and young adults, 2020565
Treatment of muscle‐invasive and advanced bladder cancer in 2020482
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society451
Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries448
Colorectal cancer statistics, 2023410
Brain and other central nervous system tumor statistics, 2021400
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations339
American Cancer Society guideline for diet and physical activity for cancer prevention337
Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine264
Metabolomics in cancer research and emerging applications in clinical oncology264
Cancer statistics for African American/Black People 2022228
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma227
American Cancer Society nutrition and physical activity guideline for cancer survivors227
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions218
Cancer statistics for the US Hispanic/Latino population, 2021171
Clinical management of metastatic colorectal cancer in the era of precision medicine164
147
Integrative oncology: Addressing the global challenges of cancer prevention and treatment140
Radiation therapy‐associated toxicity: Etiology, management, and prevention132
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies126
A systematic review of rehabilitation and exercise recommendations in oncology guidelines111
Molecular imaging in oncology: Current impact and future directions108
American Cancer Society's report on the status of cancer disparities in the United States, 202198
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions97
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation91
An update on the immune landscape in lung and head and neck cancers86
85
Innovations in research and clinical care using patient‐generated health data81
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians79
Onconephrology: The intersections between the kidney and cancer75
Intermittent fasting in the prevention and treatment of cancer73
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer73
72
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach72
Cervical cancer prevention and control in women living with human immunodeficiency virus67
Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit67
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward67
Cancer statistics, 202463
The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer61
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review59
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies59
0.021743059158325